Department of Defense Office of Inspector General
03/11/2026 | Press release | Distributed by Public on 03/12/2026 10:37
Evaluation of the DoD’s Efforts to Implement FY 2024 National Defense Authorization Act Requirements for Fentanyl (Report No. DODIG-2026-068)
Report | March 11, 2026
Evaluation of the DoD's Efforts to Implement FY 2024 National Defense Authorization Act Requirements for Fentanyl (Report No. DODIG-2026-068)
Evaluation
March
12
2026
Report No.: DODIG-2026-068
Report Type: Evaluation
Component: Evaluations
What We Did:
The objective of this evaluation was to determine the extent to which the DoD and Military Departments (MILDEPs) progressed toward: (1) having naloxone available on all military installations and in operational environments and (2) establishing a standardized tracking system for naloxone distribution and Service members' illegal use of fentanyl
SHARE
Related Documents
Department of Defense Office of Inspector General published this content on March 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 12, 2026 at 16:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]